Bain invests $300M in Boston cardiovascular disease firm
October 27, 2021 at 14:39 PM EDT
Bain Capital is investing up to $300 million into Cardurion Pharmaceuticals Inc. from both its Bain Capital Life Sciences and Bain Capital Private Equity funds.
